Literature DB >> 24464663

Pulmonary hypertension in extremely low birth weight infants: characteristics and outcomes.

Wambui Waruingi1, Maroun Jean Mhanna.   

Abstract

BACKGROUND: To determine the characteristics and outcomes of pulmonary arterial hypertension (PAH) in extremely low birth weight (ELBW) infants.
METHODS: A retrospective case-control study of all ELBW infants admitted to a level III neonatal intensive care unit (NICU) between January 1, 2003 and December 31, 2010.
RESULTS: During the study period, 450 ELBW infants were admitted. 6.4% (29/450) were diagnosed with PAH and were matched to 26 controls. The mean gestational age of infants with PAH and their controls were similar [24.5 ± 1.3 vs. 24.9 ± 1.8 weeks (P=0.26)]; however the cases were smaller at birth than were controls [640.7 ± 119.5 vs. 727.0 ± 184.5 g (P=0.04)]. The diagnosis of PAH was made at a mean postnatal age of 131.8 ± 53.7 days. Infants with PAH had a higher rate of intrauterine exposure to illicit maternal drug use [12/29 (41%) vs. 1/25 (4%); P=0.001], a longer duration of initial mechanical ventilation [74.9 ± 28.3 vs. 59.1 ± 27.8 days; P=0.04)], a higher incidence of severe BPD [23/29 (79%) vs. 13/26 (50%); P=0.02], and a greater NICU mortality rate [12/29 (41%) vs. 4/26 (15%); P=0.04].
CONCLUSION: PAH in ELBW infants is associated with maternal illicit drug use in pregnancy, longer exposure to mechanical ventilation, severe bronchopulmonary dysplasia and a significant increase in early mortality.

Entities:  

Mesh:

Year:  2014        PMID: 24464663     DOI: 10.1007/s12519-014-0464-2

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  26 in total

1.  Prospective analysis of pulmonary hypertension in extremely low birth weight infants.

Authors:  Ramachandra Bhat; Ariel A Salas; Chris Foster; Waldemar A Carlo; Namasivayam Ambalavanan
Journal:  Pediatrics       Date:  2012-02-06       Impact factor: 7.124

2.  Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Authors:  Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

3.  Pulmonary hypertension in infants with bronchopulmonary dysplasia.

Authors:  G Goodman; R M Perkin; N G Anas; D R Sperling; D A Hicks; M Rowen
Journal:  J Pediatr       Date:  1988-01       Impact factor: 4.406

4.  Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy.

Authors:  M Chaudhari; M Vogel; C Wright; J Smith; S G Haworth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-11       Impact factor: 5.747

5.  Two simple echo-Doppler measurements can accurately identify pulmonary hypertension in the large majority of patients with chronic heart failure.

Authors:  Luca Lanzarini; Alessandra Fontana; Carlo Campana; Catherine Klersy
Journal:  J Heart Lung Transplant       Date:  2005-06       Impact factor: 10.247

6.  Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.

Authors:  Matthew M Laughon; John C Langer; Carl L Bose; P Brian Smith; Namasivayam Ambalavanan; Kathleen A Kennedy; Barbara J Stoll; Susie Buchter; Abbot R Laptook; Richard A Ehrenkranz; C Michael Cotten; Deanne E Wilson-Costello; Seetha Shankaran; Krisa P Van Meurs; Alexis S Davis; Marie G Gantz; Neil N Finer; Bradley A Yoder; Roger G Faix; Waldemar A Carlo; Kurt R Schibler; Nancy S Newman; Wade Rich; Abhik Das; Rosemary D Higgins; Michele C Walsh
Journal:  Am J Respir Crit Care Med       Date:  2011-03-04       Impact factor: 21.405

7.  Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?

Authors:  Kelly M Chin; Richard N Channick; Lewis J Rubin
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

8.  Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994.

Authors:  D K Stevenson; L L Wright; J A Lemons; W Oh; S B Korones; L A Papile; C R Bauer; B J Stoll; J E Tyson; S Shankaran; A A Fanaroff; E F Donovan; R A Ehrenkranz; J Verter
Journal:  Am J Obstet Gynecol       Date:  1998-12       Impact factor: 8.661

9.  Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

Authors:  Christina D Chambers; Sonia Hernandez-Diaz; Linda J Van Marter; Martha M Werler; Carol Louik; Kenneth Lyons Jones; Allen A Mitchell
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

10.  Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; D Dunbar Ivy; Steven H Abman
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

View more
  4 in total

1.  Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertension.

Authors:  Jennifer K Trittmann; Eric Peterson; Lynette K Rogers; Bernadette Chen; Carl H Backes; Mark A Klebanoff; Leif D Nelin
Journal:  J Pediatr       Date:  2014-10-11       Impact factor: 4.406

2.  Early characteristics of infants with pulmonary hypertension in a referral neonatal intensive care unit.

Authors:  Shilpa Vyas-Read; Usama Kanaan; Prabhu Shankar; Jane Stremming; Curtis Travers; David P Carlton; Anne Fitzpatrick
Journal:  BMC Pediatr       Date:  2017-07-11       Impact factor: 2.125

3.  Multicentre prospective observational study exploring the predictive value of functional echocardiographic indices for early identification of preterm neonates at risk of developing chronic pulmonary hypertension secondary to chronic neonatal lung disease.

Authors:  Laura Thomas; Michelle Baczynski; Poorva Deshpande; Ashraf Kharrat; Sébastien Joye; Faith Zhu; Daniel Ibarra-Rios; Prakesh S Shah; Luc Mertens; Robert P Jankov; Xiang Y Ye; Elaine Neary; Joseph Ting; Michael Castaldo; Philip Levy; Aisling Smith; Afif F El-Khuffash; Regan E Giesinger; Patrick J McNamara; Dany E Weisz; Amish Jain
Journal:  BMJ Open       Date:  2021-03-31       Impact factor: 2.692

4.  Tyrosine phosphorylation of Kv1.5 is upregulated in intrauterine growth retardation rats with exaggerated pulmonary hypertension.

Authors:  L C Fu; Y Lv; Y Zhong; Q He; X Liu; L Z Du
Journal:  Braz J Med Biol Res       Date:  2017-09-12       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.